Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Prostatic Neoplasms 20Carcinoma, Non-Small-Cell Lung 20Carcinoma, Hepatocellular 15Brain Neoplasms 12Breast Neoplasms 10Pancreatic Neoplasms 9Neoplasm Metastasis 9Lung Neoplasms 5Neoplasms 4Recurrence 3Colorectal Neoplasms 3Parkinson Disease 4, Autosomal Dominant Lewy Body 2Neuroma, Acoustic 2NSCLC 2Liver Neoplasms 2Head and Neck Neoplasms 2Glioblastoma 2Esophageal Neoplasms 2Uveal Melanoma 1Urinary Bladder Neoplasms 1Stereotactic Radiotherapy; Evoximab (AK112); New Adjuvant Therapy for Non-small Cell Lung Cancer 1Stage IA - IB Non Small Cell Lung Cancer 1Squamous Cell Carcinoma of Head and Neck 1Spine Metastasis 1Spinal Neoplasms 1Spinal Bone Metastases 1Solid Tumor 1Sarcoma 1Rare Diseases 1Radiotherapy 1

Interventions

Surveys and Questionnaires 1Restraint, Physical 1Radiosurgery 1Radiation 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Genetic Diseases, Inborn × Radiosurgery × Clear all
NCT00004659 2005-06-24

Phase II Randomized Study of Stereotactic Radiosurgery Plus Fractionated Whole-Brain Radiotherapy Vs Fractionated Whole-Brain Radiotherapy Alone for Multiple Primary or Metastatic Brain Tumors

Office of Rare Diseases (ORD)

Phase 2 Unknown
40 enrolled
CNS

Brain Neoplasms, Genetic Diseases, Inborn, Rare Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡